RIP Exogen?

Discussion in 'Bioventus' started by anonymous, Mar 1, 2017 at 6:31 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Which two?
     

  2. anonymous

    anonymous Guest

    Also BCBS Idaho and BCBS Arkansas. More to follow suit.
     
  3. anonymous

    anonymous Guest

    Are they doing anything to stop this?
     
  4. anonymous

    anonymous Guest

    Yes. The company is being very proactive in its response to coverage reductions. All representatives who remember when we had a thorough coverage are being forced out. In this way, the existing representatives won't know there were better times.
     
  5. anonymous

    anonymous Guest

    BCBS Missouri is out. Guess that Trust study was more damaging then we were led to believe.
     
  6. anonymous

    anonymous Guest

    So, when I started this as a serious thread in March, I was basically laughed at. I hope it's as funny now we see this unravelling.
     
  7. anonymous

    anonymous Guest

    You didn't start this thread.


     
  8. anonymous

    anonymous Guest

    Good call
     
  9. anonymous

    anonymous Guest

    Really?? Who cares! Insurance companies are dropping Exogen like a lead balloon and you are concerned with which anonymous person started the thread??? Wow... Nice attempt at deflection.
     
  10. anonymous

    anonymous Guest

    Lol! Everyone needs to calm down. We have the best people on this....no wait, they mostly have left for greener pastures. But we have really good people working on...what??? Oh dear god help us.
     
  11. anonymous

    anonymous Guest

  12. anonymous

    anonymous Guest

    BCBS of Louisiana is out. Not good people
     
  13. anonymous

    anonymous Guest

    For those of you who think Exogen is dead; think again...... single largest month in the history of the product last month!

    It’s a shame you competitors or disgruntled ex reps who crave negative information and survive each day with the hope of a great products demise should be so lucky to carry a product with 16 level 1 studies and 900 overall pieces of positive information written about it.

    Best of luck as the culture is back on track, leaders are listening, positive changes for 2018 are close.

    Sorry to post something uplifting and accurate on here. I know it’s typically reserved for the inherently miserable and negative losers.
     
  14. anonymous

    anonymous Guest

    BCBS California and BCBS Federal just killed coverage of Exogen....you can't be serious with your post ?

    Oh....BCBS MI just decided to kill the HA Class..... Yes, I suppose everything is just awesome moving into 2018 !!
     
  15. anonymous

    anonymous Guest

    Rep here. Exogen had its best month ever and I had my best Exogen month ever with order volume and revenue. Every company has their issues. Bioventus has some issues. I am not sure HA should be point of emphasis with company. BV will get through it and adapt. Do need another non HA product though. I thnk we FINALLY have the right leader in place. I just wish TB would have made a better choice a few years ago. JA was bad for Bioventus.
     
  16. anonymous

    anonymous Guest

    Additional device in this space. OA or Fracture brace to complement current portfolio. OA cold therapy device would be great. Executive leadership is on track. Area leadership is average.
     
  17. anonymous

    anonymous Guest

    Biomet is a joke, Orthofix- maybe if you're spine only, DonJoy--just sloppy. Point is, the bone stim market is dying. Other insurance companies will follow suit with all brands eventually. The smart thing to do is just have your resume updated and ready. Send out feelers just to see if an opportunity arises outside of the bone stim market. I wouldn't want to work for any of the competitors bc they are/will be in the same boat. Be smart.